Synarc Scientific Expert to Present at Imaging and Clinical Trials Conference
San Francisco – April 25, 2008 - Synarc Inc., the world's leading provider of medical image analysis, biochemical marker, and clinical research center services to the pharmaceutical and biotechnology industries, announced that one of its top scientists, Ken Faulkner, Ph.D., will be presenting at the Imaging and Clinical Trials Conference May 6th in Cambridge, Massachusetts.
Dr. Faulkner will be presenting imaging techniques for assessing drug safety. The discussion will address the recent safety concerns associated with several drugs that have increased the need for detailed safety investigation both before and after initial regulatory approval. Dr. Faulkner will discuss how sponsors are looking to imaging techniques as important tools in determining drug safety and treatment efficacy.
Dr. Faulkner is a Synarc co-founder and Vice President of Scientific Services. He has 20 years of experience using various medical imaging techniques for pharmaceutical research and development. Dr. Faulkner leads Synarc’s strategic alliances and expansion into new therapeutic areas.
The Imaging and Clinical Trials conference is designed to provide cutting edge insights and practical information on the latest developments affecting this rapidly evolving field. By bringing together leading radiologists and researchers involved in both drug discovery and development, this event will provide a critical assessment of the clinical application of imaging in clinical trials.
Synarc was formed in 1998 and since then has contributed to the approval and availability of twenty-one leading compounds across a broad spectrum of therapeutic areas.
About Synarc
Synarc’s medical image analysis, biochemical marker and clinical research center services enable life-science industry clients to execute clinical trials accurately while decreasing the time, uncertainty, and cost of product development. Synarc has partnered with industry leaders to bring numerous leading compounds to market across a broad spectrum of therapeutic areas. Our services integrate critical aspects of clinical-trial design and execution, from protocol design and subject recruitment to regulatory liaison on behalf of our clients. Our expert radiologists and scientists are innovators in all aspects of medical image analysis and biochemical markers in drug development, and have pioneered many methods used in today’s clinical trials. Synarc has seventeen offices around the world. Synarc's medical image analysis, biochemical marker and clinical research center services are currently used in more than 200 clinical trials around the world.
